SYS-CON MEDIA Authors: RealWire News Distribution, Kevin Benedict, Jason Bloomberg, Bob Gourley, Greg Schulz

News Feed Item

The Radiant Creations Group, Inc. (RCGP) Releases Interim Period Revenue Numbers

PALM BEACH GARDENS, FL--(Marketwired - January 24, 2014) - The Radiant Creations Group, Inc. ("Radiant") (OTCQB: RCGP), developer of unique, proprietary scientific technologies for cosmetic and over-the-counter personal enhancement products and devices, with a February 28, fiscal year end is please to provide the Company's interim period net revenue and units shipped. As of January 15, 2014 the revenue and units shipped are in the amount(s) of $245,650 and 3,650 units ("Revivasol") respectively.

The Company releases this information to further define its accelerating revenue growth provided by its unique marketing platform. Through the nine month period including March 1 through November 30, 2013, Company net revenue was $102,987. Beginning December 1, 2013, revenues began to accelerate as projected in the Company's sales modeling program and is on target to reach its goal as provided in the Company's exclusive Executive Summary -- a copy of which can be obtained via e-mail upon request.

Gary D. Alexander, CFO of Radiant, stated, "We are excited to provide these interim numbers to show the investing public Radiant's extraordinary sales growth potential. We are expecting to exceed $500,000 in net sales for the last quarter of our fiscal year and continue to exponentially increase from there. Based on our revenue projection model, through this date, anticipated cash flow will propel the Company to release its second product -- Revivasol - Acne Gone -- by the middle of 2014."

About The Radiant Creations Group, Inc. (RCGP)

Radiant Creations has achieved exciting breakthroughs creating remarkable products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine ingredients believed never before used in western culture by any bioscience company.

Among these exciting discoveries is a new and superior mechanism of defense against skin deterioration and damage caused by sun exposure to ultraviolet (UV) light using the nucleotides, four "code molecules" extracted from DNA. This revolutionary mechanism also has great significance and value in many other cosmetic and non-cosmetic applications requiring UV protection, and is among Radiant Creation's licensed patented intellectual property. The technology will be implemented across numerous innovative product lines.

Cautionary Statement Concerning forward-Looking Statements:

This press release contains forward-looking statements that can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.

Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.